NCT06949059

Intravenous Hydromorphone for the Treatment of Acute Pain

Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain: A Single-Center, Prospective, Single-Arm Study

• Status: Recruiting
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.

Conditions

• Acute Chest Pain

Interventions

Type	Name	Description
DRUG	Hydromorphone	Hydromorphone 1mg was given intravenously and conventional treatment was performed at the same time.

Timeline

• Start date: 2025-01-01
• Primary completion: 2026-12-31
• Completion: 2027-12-31
• First posted: 2025-04-29
• Last updated: 2025-11-17

Locations

1 site across 1 country: China